Showing results (221-230 of 312) with videos related to

Sort By:
Pageof 32
The Journal of Rheumatology|March 28, 1998
Induction of remission in Wegener's granulomatosis with low dose methotrexateK de Groot, M Mühler, E Reinhold-Keller, et al.
The British Journal of Dermatology|November 1, 1977
Lymphocyte activation by streptococcal antigens in psoriasisW L Gross, U Packhäuser, G Hahn, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Treatment of Wegener's granulomatosisL Briedigkeit, M Ulmer, U Göbel, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|April 1, 1993
[Therapy of Wegener's granulomatosis. Experiences with conventional and stage-adjusted treatment in 111 patients over 24 years]L Briedigkeit, M Ulmer, E Rheinhold-Keller, et al.
Deutsche Medizinische Wochenschrift (1946)|October 27, 1997
[Lymphomatoid granulomatosis--remission induction with interferon-alpha 2b]C Richter, A Schnabel, K M Müller, et al.
International Journal of Immunogenetics|February 3, 2005
Association study of Wegener granulomatosis and the functionally relevant A645G polymorphism in the bactericidal/permeability increasing protein (BPI) geneP Jagiello, W Klein, H Schultz, et al.
The American Journal of Medicine|October 1, 1996
Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitidesM W Boehme, W H Schmitt, P Youinou, et al.
Arthritis and Rheumatism|January 22, 2000
Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodiesH K Choi, P Lamprecht, J L Niles, et al.
Cytokine|May 11, 2000
Neutrophils synthesize and activate TGFbeta2C H Szymkowiak, E Csernok, D Reinhold, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 13, 2000
Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPIH Schultz, E Csernok, A Schuster, et al.
Pageof 32